Preview

Pharmacokinetics and Pharmacodynamics

Advanced search

Dimeric dipeptide mimetics of the nerve growth factor loops 3 and 4 are active in a model of ischemic stroke

Abstract

Pharmacological activity of dimeric dipeptide mimetics of the nerve growth factor loops 3 and 4, correspondingly GTS-115 and GK-2, was studied in a model of ischemic stroke, induced by transient middle cerebral artery occlusion in rats. The both compounds, at i.p. subchronic administration (0,5-1 mg/kg/day, 7 days, beginning at 4 hours after surgery), significantly reduced cerebral infarct volume as was estimated by morphometry of 2,3,5-triphenyltetrazolium chloride (TTC) -stained brain slices: GTS-115 by 25% and GK-2 by 35%. Mimetic of NGF loop 4 (GK-2), which is the most active compound, was selected for further development as a potential therapeutic agent.

About the Authors

P. Y. Povarnina
FSBI «Zakusov Institute of Pharmacology»
Russian Federation


T. A. Gudasheva
FSBI «Zakusov Institute of Pharmacology»
Russian Federation


S. B. Seredenin
FSBI «Zakusov Institute of Pharmacology»
Russian Federation


References

1. Середенин С.Б., Гудашева Т.А. Дипептидные миметики нейротрофинов NGF и BDNF. Патент РФ № 2410392.

2. Гудашева Т.А., Тарасюк А.В., Сазонова Н.М., Логвинов И.О., Поварнина П.Ю., Константинопольский М.А., Антипова Т.А., Середенин С.Б. Дизайн, синтез и нейропротекторные эффекты димерного дипептидного миметика 3-й петли фактора роста нервов ГТС-115. Биоорганическая химия. 2016 (в печати).

3. Гудашева Т.А., Антипова Т.А., Середенин С.Б. Новые низкомолекулярные миметики фактора роста нервов. Доклады Академии Наук. 2010; 434: 4: 262-265.

4. Гудашева Т.А., Антипова Т.А., Константинопольский М.А., Поварнина П.Ю., Середенин С.Б. Оригинальный дипептидный миметик фактора роста нервов ГK-2 избирательно активирует пострецепторные пути TrkA, не вызывая побочных действий полноразмерного неротрофина. Доклады Академии наук. 2014; 456: 1: 88-91.

5. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 1: 84-91.

6. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000; 10: 3: 381-391.

7. Obata K., Noguchi K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci. 2004; 74: 21: 2643-5263.


Review

For citations:


Povarnina P.Y., Gudasheva T.A., Seredenin S.B. Dimeric dipeptide mimetics of the nerve growth factor loops 3 and 4 are active in a model of ischemic stroke. Pharmacokinetics and Pharmacodynamics. 2016;(3):34-37. (In Russ.)

Views: 558


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7836 (Print)
ISSN 2686-8830 (Online)